Spring Bank Pharmaceuticals, Inc. 4/A
4/A · Spring Bank Pharmaceuticals, Inc. · Filed Aug 16, 2016
Insider Transaction Report
Form 4/AAmended
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-08-10$10.81/sh+1,600$17,300→ 32,850 total - Purchase
Common Stock
2016-08-12$11.32/sh+1,000$11,318→ 33,850 total